Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Parathyroid Neoplasms 2Hyperparathyroidism, Primary 2

Interventions

Cinacalcet 3belinostat 2Trastuzumab 2Parathyroidectomy 2Denosumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1gallium Ga 68 dotatate 1fluorodopa F 18 1evocalcet 1entinostat 1acetaminophen, codeine drug combination 1Tramadol 1Tablets 1Standard of Care 1Sodium Chloride 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy 1Gefitinib 1Fluorouracil 1Drug Therapy 1Dacarbazine 1Control Groups 1Congresses as Topic 1Capsules 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Parathyroid Neoplasms × Parathyroidectomy × Clear all
NCT06779760 2025-01-17

NIRAF MIVAP

Aristotle University Of Thessaloniki

Completed
24 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT03011736 2021-08-12

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

Roswell Park Cancer Institute

Phase NA Completed
6 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡